Abstract
Chronic Obstructive pulmonary disease (COPD) is a lung disease characterized by chronic inflammation, and mucus hypersecretion. Currently, curative treatment does not exist, and some patients develop resistance to corticosteroid drugs. Gene therapy could be a novel approach to treat the disease. However, the effectiveness of gene vectors in the airways is decreased by the presence of mucus that acts as a barrier. The aim of this study is to develop an in vitro model, able of cytokine production and mucus secretion; in the perspective of testing new drug including mucolytic gene therapy vectors. We used three human airway epithelial lines (A549, Calu-3 and NCI-H292) stimulated with different concentrations of CSE (Cigarette Smoke Extract) alone or in association with LPS (lipopolysaccharides) , for 24 or 48 hours. NCI-H292 and Calu-3 cells were also co-cultured in the same conditions. Then, we evaluated MUC5AC, IL8/CXCL8, GROα/CXCL1 and MCP1/CCL2 gene expression by RT-qPCR and their secretion by ELISA. Finally, we also observed MUC5AC production from NCI-H292 by immunohistochemistry. CSE alone or with LPS did not impact MUC5AC gene expression, in A549 cells. In contrast, LPS (0.1 μg/mL) increased IL8/CXCL8, GROα/CXCL1 and MCP1/CCL2 release. When CSE associated with LPS, there was an additive effect on cytokine release. Regarding Calu-3 cells, treatment with CSE, LPS, or both, did not affect MUC5AC gene expression, neither cytokine secretions. For NCI-H292 cells, CSE alone increased MUC5AC gene expression and an additive effect was observed when CSE was associated with LPS. LPS at low concentrations triggered some MUC5AC and IL8/CXCL8 release, which was more important when LPS was associated with CSE; but not for GROα/CXCL1. NCI-H292 cells did not release MCP1/CCL2. In the NCI-H292 and Calu-3 co-culture, CSE and LPS increased MUC5AC gene expression, but CSE did not affect cytokine secretion. LPS alone increased IL8/CXCL8 secretion, but not GROα/CXCL1 or MCP1/CCL2. Our results show that NCI-H292 cells appear as the best model to evaluate the efficacy of gene vectors, as they are able to produce mucins and cytokines, after CSE and LPS exposure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.